ARTICLE | Company News
UnitedHealth Group covering Spinraza
February 2, 2017 1:47 AM UTC
In a policy update, UnitedHealth Group Inc. (NYSE:UNH) said it will cover Spinraza nusinersen from Biogen Inc. (NASDAQ:BIIB) to treat spinal muscular atrophy (SMA) type 1, 2 or 3 in patients with at least two copies of survival of motor neuron 2 centromeric (SMN2) and certain mutations or deletions including survival of motor neuron 1 telomeric (SMN1).
The coverage is effective April 1...